Class II

Drug Recall: Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Lim

Merck Sharp & Dohme LLC · December 12, 2025

Reason for Recall

Presence of particulate matter: potential presence of metal particulates in the product.

Product Description

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

3 - single dose kits

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0241-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.